Background. Untreated syphilis during pregnancy can result in wide spectrum of fetal clinical manifestations including death. Peaks in Congenital Syphilis (CS) usually occur one year after peaks in Primary and Secondary (P&S) syphilis in women. Between 2007 and 2011, total number of female P&S syphilis cases in Chicago increased by 195% (from 20 to 59 cases) in parallel with an increase in the total number of CS cases ( from 12 cases in 2008 to 22 cases in 2012). At the same time, national rates of CS cases decreased by 27% to 7.8 cases/per 100,000 live births, while during the same period CS rates in Chicago increased by 103% (from 26.5 to 53.7 cases).
Methods. Retrospective analysis of all 2008-2012 surveillance data of CS cases reported to Chicago Department of Public Health (CDPH) was performed.
Results. Out of 73 CS reported cases, 70(96%) were presumptive cases and 3 (4%) were CS stillborns. Mothers who delivered newborns with CS were predominantly single (68%), young (median age 22) and African American (82%). Among the mothers who gave birth to infants with CS: 53% (39/73) were diagnosed with early syphilis (9 P&S syphilis and 30 early latent syphilis). Only one mother was HIV+.
Over 40% (30/73) of infants with CS were born to mothers who did not receive any prenatal care (PNC) and almost 60% (43/73) of the CS cases were among infants whose mothers received PNC and were attributed to inadequate testing and/or treatment.
Twenty six cases were not tested or tested within 30 days prior to delivery. Among females who were tested >30 days to delivery, twelve females were not treated, four of them were treated less than 30 days prior to delivery, and eight females had inadequate treatment or seroconverted at the time of delivery.
Conclusion. The increase in the number of CS cases in Chicago is attributed to multiple factors that include the increase in the number of female P&S syphilis cases, lack of early access to prenatal care, and inadequate testing and treatment by clinical providers.
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